** Medical device maker Intuitive Surgical's ISRG.O shares up 3% at $492.79 after Q1 results beat
** Co posts adj. EPS of $1.81, beating analysts' estimates of $1.72 - as per data compiled by LSEG
** Reports Q1 revenue of $2.25 bln versus estimates of $2.19 bln
** ISRG projects 2025 adj. gross profit margin in a range of 65% to 66.5% of revenue, lower than last year's 69.1% due to tariffs
** Co says U.S. tariffs to weigh on its business for the rest of the year
** At least 12 brokerages cut target price on stock, citing tariffs; J.P. Morgan cuts PT to $605 from $675
** Piper Sandler lowers PT to $575 from $670; cites tariff-related lowered gross profit margin guidance
** "While the tariff-related GM guide-down is a touch disappointing - we believe this headwind will be transitory and that ISRG has essentially built-in a 'worst case' scenario," -brokerage
** 21 out of 33 brokerages rate stock "buy" or higher, 12 "hold"; Median PT is $607.45 - data compiled by LSEG
** Including current move, ISRG down 5.6% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.